Study identification

EU PAS number

EUPAS1000000493

Study ID

1000000493

Official title and acronym

Meningioma medroxyprogesterone feasibility assessment in the IDA Germany and IMRD UK databases

DARWIN EU® study

No

Study countries

Germany
United Kingdom

Study description

A descriptive study to measure exposure to medroxyprogesterone in women, and the number of women meningioma who have been prescribed medroxyprogesterone. These descriptive data will be used to inform decision making around the feasibility of a larger network study.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Daniel Morales

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:

Study start date

Planned:
Actual:

Data analysis start date

Planned:

Date of final study report

Planned:
Actual:
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable